Key Highlights

  • Ocean Sciences (ASX:OSS) has secured $700,000 in firm Placement commitments at $0.011 per share.
  • Resonance Health (ASX:RHT) has appointed a Head of Clinical Site Development & Expansion, starting 1 December 2026.
  • SRJ Technologies (ASX:SRJ) has changed its chair and chief executive, with Ben Lumley appointed interim CEO.
  • The three announcements describe corporate and governance steps rather than operating results.

Three ASX-listed companies released corporate announcements on 4 November 2026. Ocean Sciences Ltd (ASX:OSS) secured placement commitments, Resonance Health Limited (ASX:RHT) announced a senior executive appointment, and SRJ Technologies Group Plc (ASX:SRJ) disclosed changes to its board and executive leadership.

Ocean Sciences and the Placement

Ocean Sciences will issue 63,636,364 shares at $0.011 each, raising $700,000 before costs. Each placement share carries one option exercisable at $0.03 and expiring three years from issue. The company plans to use the proceeds for seaweed operations in Indonesia, a new innovation centre, research and working capital.

The Ocean Sciences placement was secured from directors and professional investors, with the directors' portion requiring Shareholder approval. The company says the proceeds will fund its seaweed expansion and the development of its innovation centre.

Resonance Health and the Expansion Leader

Resonance has appointed an executive with more than 25 years' experience to lead the east-coast expansion of its TrialsWest network, with the appointment starting 1 December 2026. The role is funded by the recent placement, and the first east-coast sites are expected from H2 FY27.

Resonance's appointment is aimed at the east-coast network, which is expected to add sites at about two a year from H2 FY27. The placement supports the expansion, linking the company's capital raising with its operational rollout.

SRJ and the Leadership Changes

SRJ's chair, George Gourlay, has resigned, and existing director Mark Lindh has been appointed chair. Chief Executive Officer Kurt Reeves has left by mutual agreement, and Ben Lumley has been appointed interim chief executive.

SRJ's board changes combine a chair transition with an interim chief executive and the departure of the previous chief executive by mutual agreement. The company ties these changes to its focus on operational performance and commercial execution.

Governance Themes Across the Releases

The three releases cover a capital raise, a leadership appointment and a board and executive change. Each sets out its own rationale, and the announcements do not describe any link between the three companies.

The three releases differ in purpose, covering a capital raise, a senior appointment and a governance change. The announcements do not report financial results, so the implications for each company will become clearer through later updates.

Final Word

The three announcements set out a placement, a senior appointment and a leadership transition, each with its own timeline and conditions. Ocean Sciences' placement remains subject to shareholder approval for the director component, Resonance's appointment begins on 1 December 2026, and SRJ's interim arrangement has no permanent successor named. Further announcements will show how these changes are implemented. Each company's announcement sets out the terms or details that apply to its own event, and the releases do not link those events together. Further disclosures will be the reference point for the next phase of each transaction or appointment.